Stock ALCJ CROSSJECT
Add to a list
To use this feature you must be a member
Log inSign up

Financials Crossject

Equities

ALCJ

FR0011716265

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris
Other stock markets
 11:35:20 2024-06-07 am EDT 		5-day change 1st Jan Change
1.896 EUR +0.85% Intraday chart for Crossject -17.92% -61.85%
Jun. 05 Crossject: successful capital increase CF
Jun. 05 CROSSJECT : Success of the capital increase AL

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 46.16 77.73 78.44 99.04 189 80.81 - -
Enterprise Value (EV) 1 46.7 77.73 88.99 105.4 189 107.6 96.11 70.41
P/E ratio -6.48 x -7.48 x -6.95 x -11 x - -7.9 x 3.79 x 2.67 x
Yield - - - - - - - -
Capitalization / Revenue 7.7 x 13.6 x 86 x 104 x 14.7 x 9.98 x 1.54 x 1.18 x
EV / Revenue 7.79 x 13.6 x 97.6 x 110 x 14.7 x 13.3 x 1.83 x 1.03 x
EV / EBITDA -9.64 x -12.7 x -12.1 x -15.2 x -30.9 x -10.2 x 2.94 x 1.51 x
EV / FCF - - - - - -8.54 x 5.79 x 2.29 x
FCF Yield - - - - - -11.7% 17.3% 43.6%
Price to Book 15.4 x -64.3 x -13.4 x 44.6 x - -9.98 x 6.12 x 1.86 x
Nbr of stocks (in thousands) 20,072 25,361 27,523 30,057 38,026 42,620 - -
Reference price 2 2.300 3.065 2.850 3.295 4.970 1.896 1.896 1.896
Announcement Date 3/26/20 3/30/21 3/24/22 3/20/23 4/2/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5.994 5.731 0.912 0.954 12.83 8.1 52.6 68.5
EBITDA 1 -4.846 -6.116 -7.333 -6.93 -6.115 -10.5 32.7 46.5
EBIT 1 -8.643 -10.67 -11.82 -13.29 -12.3 -10.9 30.1 43.1
Operating Margin -144.19% -186.22% -1,296.38% -1,392.87% -95.9% -134.57% 57.22% 62.92%
Earnings before Tax (EBT) -8.533 -10.92 -12.52 -13.38 -11.33 - - -
Net income 1 - - - - -8.467 -10.9 22.6 32.3
Net margin - - - - -66.01% -134.57% 42.97% 47.15%
EPS 2 -0.3551 -0.4100 -0.4100 -0.3000 - -0.2400 0.5000 0.7100
Free Cash Flow 1 - - - - - -12.6 16.6 30.7
FCF margin - - - - - -155.56% 31.56% 44.82%
FCF Conversion (EBITDA) - - - - - - 50.76% 66.02%
FCF Conversion (Net income) - - - - - - 73.45% 95.05%
Dividend per Share - - - - - - - -
Announcement Date 3/26/20 3/30/21 3/24/22 3/20/23 4/2/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 0.54 - 10.5 6.36 - 26.8 15.3 -
Net Cash position 1 - - - - - - - 10.4
Leverage (Debt/EBITDA) -0.1108 x - -1.439 x -0.9172 x - -2.552 x 0.4679 x -
Free Cash Flow 1 - - - - - -12.6 16.6 30.7
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 0.1500 -0.0500 -0.2100 0.0700 - -0.1900 0.3100 1.020
Cash Flow per Share -0.2700 -0.2300 -0.2300 -0.1400 - - - -
Capex 1 - - - - - 0.3 2.1 2.7
Capex / Sales - - - - - 3.7% 3.99% 3.94%
Announcement Date 3/26/20 3/30/21 3/24/22 3/20/23 4/2/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Crossject

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.896 EUR
Average target price
4.8 EUR
Spread / Average Target
+153.16%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Drug Delivery Systems

1st Jan change Capi.
CROSSJECT Stock Crossject
-61.85% 87.34M
SEDANA MEDICAL AB Stock Sedana Medical AB
+14.85% 251M
Drug Delivery Systems
  1. Stock Market
  2. Equities
  3. ALCJ Stock
  4. Financials Crossject